The College of American Pathologists (CAP) has signed a memorandum of understanding (MOU) with the Centers for Disease Control and Prevention (CDC) to provide assistance and expertise with surge testing during public health emergencies.
CAP said on Monday that under the memorandum, it will collaborate with the CDC and other partners and government agencies to support surge testing capacity when public health emergencies and emerging public health threats arise.
CAP will serve as a communications hub between CAP member experts, CAP committees, and entities participating in the MOU, and will leverage its accredited laboratories to augment external surge testing capacity.
CAP added that it will also collect capability data from accredited laboratories to identify those with the capacity to support a national response, including community-based testing for vulnerable patient communities.
"Pathologists have been on the frontline of the COVID-19 crisis, responsible for developing and selecting new test methodologies; validating and approving testing for patient use; and expanding the testing capabilities of the communities they serve to meet urgent and evolving needs," CAP President Dr. Emily Volk noted in a statement.